Ginkgo Bioworks to go public in $17.5B SPAC deal

Ginkgo Bioworks bills itself as "the organism company," making custom microbes by programming cellular DNA. As a public firm, Ginkgo plans to continue that work, with ambitious plans to expand into "every physical goods company."
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news